AstraZeneca Webinar Discusses Extended Uniformity of Dosage Unit Testing of Pharmaceutical Tablets Using TRS

TRS100 Quantitative Pharmaceutical Analysis System

Transmission Raman spectroscopy (TRS) is non-destructive and high throughput, so can be applied to extended uniformity of dosage unit testing and enhanced control strategies aiming at real-time release for batch and continuous operations. Hear Anders Sparén, Associate Principal Scientist at AstraZeneca, present his team’s work showing why TRS is an ideal technique for the assessment of assay, uniformity of dosage unit, and polymorphs in tablets and capsules.

Key Learning Objectives:

  • Learn how AstraZeneca utilizes transmission Raman analytical workflows in PAT
  • Learn different approaches for interpreting and evaluating spectral data
  • Find out more about the features and benefits of transmission Raman towards an enhanced control strategy
  • Find out how rapid, nondestructive technology can benefit your lab

Download the flyer and register for the event.

Was this helpful?